Canada Blood-based Biomaker For Sports Medicine Market Size & Outlook
Canada blood-based biomaker for sports medicine market, 2018-2030 (US$M)
Related Markets
Canada blood-based biomaker for sports medicine market highlights
- The Canada blood-based biomaker for sports medicine market generated a revenue of USD 34.8 million in 2023 and is expected to reach USD 60.8 million by 2030.
- The Canada market is expected to grow at a CAGR of 8.3% from 2024 to 2030.
- In terms of segment, ck was the largest revenue generating type in 2023.
- CRP is the most lucrative type segment registering the fastest growth during the forecast period.
Blood-based biomaker for sports medicine market data book summary
| Market revenue in 2023 | USD 34.8 million |
| Market revenue in 2030 | USD 60.8 million |
| Growth rate | 8.3% (CAGR from 2023 to 2030) |
| Largest segment | Ck |
| Fastest growing segment | CRP |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | CK, Myoglobin, Lactate, WBC, Urea, CRP, Lipid and Protein Hydroperoxides, IL-6 |
Other key industry trends
- In terms of revenue, Canada accounted for 5.2% of the global blood-based biomaker for sports medicine market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. blood-based biomaker for sports medicine market is projected to lead the regional market in terms of revenue in 2030.
- U.S. is the fastest growing regional market in North America and is projected to reach USD 425.8 million by 2030.
Ck was the largest segment with a revenue share of 18.1% in 2023. Horizon Databook has segmented the Canada blood-based biomaker for sports medicine market based on ck, myoglobin, lactate, wbc, urea, crp, lipid and protein hydroperoxides, il-6 covering the revenue growth of each sub-segment from 2018 to 2030.
The high prevalence of sports injuries in Canada, driven by widespread participation in hockey, soccer, and skiing, is expected to fuel the market growth for blood-based biomarkers in sports medicine. According to a report published in Scholastica in December 2022, over 10 years of competition, around 3,160 injuries were reported among 8,710 male athletes, and 3,272 injuries were reported among 8,391 female athletes.
The injury incidence rates were 362.8 per 1,000 male athletes and 389.9 per 1,000 female athletes. Female athletes were found to have 1.12 times higher odds of injury and 1.37 times higher odds of illness compared to their male counterparts.
As more Canadians engage in sports, the need for advanced tools to diagnose, manage, and prevent injuries has become increasingly critical. Blood-based biomarkers offer a noninvasive way to detect early signs of injuries, such as concussions and muscle damage, enabling quicker & more accurate interventions.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Blood-based Biomaker for Sports Medicine Market Scope
Blood-based Biomaker for Sports Medicine Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Canada blood-based biomaker for sports medicine market size, by type, 2018-2030 (US$M)
Canada Blood-based Biomaker for Sports Medicine Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
